EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement: Incidence, Predictors, and Association With Reduced Ischemic Stroke Risk

Omar Saleh iD, Nicholas J Valle iD, Shinjer Li, Saleh Mostafa, Israa Saleh, Raymond Benza, Deepak R Talreja, Matthew R Summers

Catheterization and Cardiovascular Interventions · 2026-05 · 107 (6) · 2124-2134

DOI: 10.1002/ccd.70579 ↗

At a glance

Journal article in Catheterization and Cardiovascular Interventions, published online on 2026-04-01. Written by Omar Saleh and 7 co-authors. Institution: Department of Internal Medicine, Macon and Joan Brock Virginia Health Sciences at Old Dominion University, Eastern Virginia Medical School, Norfolk, …. Major MEDLINE topics: Transcatheter Aortic Valve Replacement, Pacemaker, Artificial, Ischemic Stroke, Cardiac Pacing, Artificial. 24 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Development of conduction abnormalities requiring pacing after transcatheter aortic valve replacement (TAVR) is relatively common. The effects of post‐TAVR permanent pacemaker (PPM) implantation on mortality, ischemic stroke, and cardiovascular outcomes remain incompletely characterized.

Aims

To evaluate the incidence, predictors, and cardiovascular outcomes of post‐TAVR permanent pacemaker implantation, including its association with 1‐year ischemic stroke risk.

Methods

Adults undergoing TAVR (2008–2019; n = 1101) were evaluated. Patients with prior PPM ( n = 104) and/or valve‐in‐valve or redo TAVR ( n = 11) were excluded. PPM placement was identified post‐indexed TAVR admission based on procedure codes, including both in‐hospital and post‐discharge implantations. Primary outcomes included 1‐year mortality, major adverse cardiovascular events (MACE), myocardial infarction (MI), and ischemic stroke. Multivariate logistic regression was performed to identify independent predictors of 1‐year ischemic stroke.

Results

Within the TAVR cohort ( N = 1101), 158 patients (14.4%) received PPM within 1‐year, including 135 (12.3%) in‐hospital and 23 post‐discharge. PPM was not associated with a significant difference in 1‐year mortality (15.8% vs. 14.7%, p = 0.816) or 1‐year MACE (20.9% vs. 21.0%, p = 1.000). However, PPM was associated with significantly lower ischemic stroke rate at 1 year (1.3% vs. 4.8%, p = 0.044). In multivariate analysis adjusting for age, sex, and comorbidities, PPM was associated with 77% lower risk of 1‐year ischemic stroke (adjusted OR 0.234, 95% CI 0.056–0.977, p = 0.046). Late PPM implantation (> 3 days) was associated with numerically higher 1‐year mortality (30.0% vs. 14.3%, p = 0.647) and MACE (36.7% vs. 17.1%, p = 0.119) compared to early implantation, though these outcomes did not reach statistical significance.

Conclusion

PPM after TAVR was not associated with increased mortality or MACE but was independently associated with significantly lower ischemic stroke risk. Late PPM implantation showed a trend toward worse outcomes. These findings suggest that appropriately indicated PPM may confer cerebrovascular protection, and early implantation when indicated may be preferable. These findings warrant further validation in prospective studies.

Subjects

MeSH terms (MEDLINE)

Transcatheter Aortic Valve ReplacementPacemaker, ArtificialIschemic StrokeCardiac Pacing, ArtificialAortic Valve StenosisArrhythmias, CardiacHumansFemaleMaleRisk FactorsIncidenceAged, 80 and overRisk AssessmentTime FactorsAgedTreatment OutcomeRetrospective StudiesProtective Factors

Author keywords

atrioventricular blockcardiovascular outcomesconduction abnormalityischemic strokepermanent pacemakertranscatheter aortic valve replacement

Authors and institutions

  • Department of Internal Medicine, Macon and Joan Brock Virginia Health Sciences at Old Dominion University, Eastern Virginia Medical School, Norfolk, Virginia, USA.
  • Eastern Virginia Medical School, Macon and Joan Brock Virginia Health Sciences at Old Dominion University, Norfolk, Virginia, USA.
  • Department of Cardiology, University of Arizona, Tucson, Arizona, USA.
  • Department of Structural Cardiology, Sentara Medical Group, Sentara Health, Virginia Beach, Virginia, USA.

ORCID profiles: Omar Saleh, Nicholas J Valle

Cite

APA

Saleh, O., Valle, N. J., Li, S., Mostafa, S., Saleh, I., Benza, R., Talreja, D. R., & Summers, M. R. (2026). Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement: Incidence, Predictors, and Association With Reduced Ischemic Stroke Risk. Catheterization and Cardiovascular Interventions, 107(6), 2124-2134. https://doi.org/10.1002/ccd.70579

Vancouver

Saleh O, Valle NJ, Li S, Mostafa S, Saleh I, Benza R, et al. Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement: Incidence, Predictors, and Association With Reduced Ischemic Stroke Risk. Catheterization and Cardiovascular Interventions. 2026;107(6):2124-2134. doi:10.1002/ccd.70579

BibTeX
@article{Saleh2026,
  author = {Saleh, Omar and Valle, Nicholas J and Li, Shinjer and Mostafa, Saleh and Saleh, Israa and Benza, Raymond and Talreja, Deepak R and Summers, Matthew R},
  title = {Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement: Incidence, Predictors, and Association With Reduced Ischemic Stroke Risk},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2026},
  volume = {107},
  number = {6},
  pages = {2124--2134},
  doi = {10.1002/ccd.70579}
}
Start for free →